Oxoid has announced that the next Oxoid Infection Control Seminar will take place on 2 June 2009 at The Belfry in West Midlands, UK.
This event is provided as an educational service to consultant microbiologists, laboratory managers/personnel and infection-control professionals.
This year's topics and speakers will include: An Outbreak of the New Superbug - MSSA (Dr Tim Boswell, Nottingham University Hospital NHS Trust); The Implications of PVL for Infection Control (Angela Kearns, Health Protection Agency); Implications and Benefits of Implementation of MRSA Screening Policy (Steve Farley and Yashpal Delele, Dudley Group of Hospitals NHS Trust); European Committee on Antimicrobial Susceptibility Testing (EUCAST) Update, (Gunnar Kahlmeter, Vaxjo Hospital, Sweden); New Technology, Friend or Foe - How Infection-Control Needs are Impacting Hospital Design (Martin Kiernan, President of the Infection Prevention Society); Standards and Performance Indicators for Healthcare Associated Infections and Antimicrobial Resistance in Europe (Professor Barry Cookson, Health Protection Agency).
This study day is accredited by the Institute of Biomedical Scientists (seven credits) and the Royal College of Pathologists (five credits) and accreditation from the Royal College of Nursing has been sought.
The seminar is also a great opportunity to mix with colleagues and share current thinking on healthcare-associated infection and infection-control matters.
Places can be reserved by contacting Fiona Macrae, seminar manager, via Oxoid's website.
Places are limited and are allocated on a first-come, first-served basis.
Lunch is provided.
